- December 16, 2015Read more
Cohen Veterans Bioscience held its first Preclinical PTSD Working Group meeting in Hollywood, Florida on December 5, 2015. This event was co-chaired by Dr. Kerry Ressler, Chief Scientific Officer at McLean Hospital and Professor of Psychiatry at Harvard Medical School, and Dr. Magali Haas, CEO of Cohen Veterans Bioscience. The Cohen Veterans Bioscience Preclinical Working Group is designed to bring together world-leading clinical researchers and preclinical scientists from academia and industry with the goal of informing Cohen Veterans Bioscience’s preclinical development strategy.
- October 23, 2015Read more
Cohen Veterans Bioscience CEO & President, Dr. Magali Haas, participated in the CNS Summit 2015, which convened from October 8-11 in Boca Raton, Florida. There, Dr. Haas lent her extensive expertise in pharmaceutical strategy, clinical research, and biotechnology to the Keynote Session, “What Will be the Impact of Silicon Valley on Drug Development?”
- February 1, 2015Read more
The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.